References

1.

Bernsten C, Bjorkman I, Caramona M, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001;18(1):63–77. [PubMed: 11232739]

2.

Sturgess IK, McElnay JC, Hughes CM, et al. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003 Oct;25(5):218–26. [PubMed: 14584229]

3.

Blakey SA, Hixson-Wallace JA. Clinical and economic effects of pharmacy services in a geriatric ambulatory clinic. Pharmacotherapy. 2000;(10):1198–203. (Structured abstract) [PubMed: 11034043]

4.

Brummel AR, Soliman AM, Carlson AM, et al. Optimal diabetes care outcomes following face-to-face medication therapy management services. Popul Health Manag. 2013 Feb;16(1):28–34. [PubMed: 23113628]

5.

Soliman AM, Carlson AM, MacLehose RF, et al. Patient characteristics predicting the frequency of medication therapy management visits for patients with diabetes. Clin Ther. 2013 Apr;35(4):534–40. [PubMed: 23541131]

6.

Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010 Apr;16(3):185–95. [PMC free article: PMC10437567] [PubMed: 20331323]

7.

Carter BL, Barnette DJ, Chrischilles E, et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural settin. Pharmacotherapy. 1997 Nov-Dec;17(6):1274–85. [PubMed: 9399611]

8.

Barnette DJ, Murphy CM, Carter BL. Clinical skill development for community pharmacists. J Am Pharm Assoc (Wash). 1996 Sep;NS36(9):573–80. [PubMed: 8824077]

9.

Chrischilles EA, Carter BL, Lund BC, et al. Evaluation of the Iowa Medicaid pharmaceutical case management progra. J Am Pharm Assoc (2003). 2004 May-Jun;44(3):337–49. [PubMed: 15191244]

10.

Christensen DB, Roth M, Trygstad T, et al. Evaluation of a pilot medication therapy management project within the North Carolina State Health Pla. J Am Pharm Assoc (2003). 2007 Jul-Aug;47(4):471–83. [PubMed: 17616493]

11.

Clifford RM, Batty KT, Davis TME, et al. A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. Int J Pharm Pract. 2002;10(2):85–9.

12.

Fischer LR, Scott LM, Boonstra DM, et al. Pharmaceutical care for patients with chronic conditions. J Am Pharm Assoc (Wash). 2000 Mar-Apr;40(2):174–80. [PubMed: 10730021]

13.

Fischer LR, Defor TA, Cooper S, et al. Pharmaceutical care and health care utilization in an HM. Eff Clin Pract. 2002 Mar-Apr;5(2):49–57. [PubMed: 11990212]

14.

Fox D, Ried LD, Klein GE, et al. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabete. J Am Pharm Assoc (2003). 2009 Mar-Apr;49(2):192–9. [PubMed: 19289345]

15.

Gattis WA, Hasselblad V, Whellan DJ, et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999 Sep 13;159(16):1939–45. [PubMed: 10493325]

16.

Grymonpre RE, Williamson DA, Montgomery PR. Impact of a pharmaceutical care model for non-institutionalised elderly: Results of a randomised, controlled trial. Int J Pharm Pract. 2001;(4):235–41.

17.

Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996 Apr;100(4):428–37. [PubMed: 8610730]

18.

Cowper PA, Weinberger M, Hanlon JT, et al. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatient. Pharmacotherapy. 1998 Mar-Apr;18(2):327–32. [PubMed: 9545151]

19.

Hirsch JD, Gonzales M, Rosenquist A, et al. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS. J Manag Care Pharm. 2011 Apr;17(3):213–23. [PMC free article: PMC10437600] [PubMed: 21434698]

20.

Hirsch JD, Rosenquist A, Best BM, et al. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiarie. J Manag Care Pharm. 2009 Jan-Feb;15(1):32–41. [PMC free article: PMC10438302] [PubMed: 19125548]

21.

Rosenquist A, Best BM, Miller TA, et al. Medication therapy management services in community pharmacy: a pilot programme in HIV specialty pharmacies. J Eval Clin Pract. 2010 Dec;16(6):1142–6. [PubMed: 21143346]

22.

Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008 Mar-Apr;48(2):203–11. 3 p following 11. [PubMed: 18359733]

23.

Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract. 1995 Nov;41(5):469–72. [PubMed: 7595265]

24.

Jeong EW, Gallagher MW, Fredriks D, et al. Impact of a pharmacist-managed medication therapy management (MTM) progra. ASHP Midyear Clinical Meeting. 2007;42(DEC)

25.

Jeong E, Hui R, Gallagher M, et al. Clinical, Economical and Humanistic Outcomes from a Pharmacist-managed Medication Therapy Management Program (MTMP) in Medicare Patients from an Integrated Healthcare Delivery System. Kaiser Permanante; 2009. pp. 1–31.

26.

Jeong E, Pitcher K, Fredriks D, et al. Clinical & Safety Outcomes from a Pharmacist-managed Medicare Medication Therapy Management Program. Kaiser Permanente;

27.

Jeong E, Deguzman L, Fredriks D, et al. Comprehensive Medication Reviews Improve Hospitalization and Emergency Department Outcomes. Kaiser Permanente; 2012.

28.

Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001 May;30(3):205–11. [PubMed: 11443021]

29.

Malone DC, Carter BL, Billups SJ, et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000 Oct;20(10):1149–58. [PubMed: 11034037]

30.

Ellis SL, Billups SJ, Malone DC, et al. Types of interventions made by clinical pharmacists in the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000 Apr;20(4):429–35. [PubMed: 10772374]

31.

Malone DC, Carter BL, Billups SJ, et al. Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems? Med Car. 2001 Feb;39(2):113–22. [PubMed: 11176549]

32.

Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000 Dec;20(12):1508–16. [PubMed: 11130223]

33.

Marques LA, Galduroz JC, Fernandes MR, et al. Assessment of the effectiveness of pharmacotherapy follow-up in patients treated for depression. J Manag Care Pharm. 2013 Apr;19(3):218–27. [PMC free article: PMC10438347] [PubMed: 23537456]

34.

Marrufo G, Dixit A, Perlroth D, et al. Medication Therapy Management in a Chronically Ill Population: Interim Report. Baltimore, MD: Services Centers for Medicare & Medicaid Services; 2013. (Prepared by Acumen LLC under Contract #HHSM-500-2011-00012I/TOT#0001)

35.

Perlroth D, Marrufo G, Montesinos A, et al. Medication Therapy Management in Chronically Ill Populations: Final Report. Baltimore, MD: Centers for Medicare & Medicaid Services (CMS) Center for Medicare & Medicaid Innovation; 2013. Contract # HHSM-500-2011-00012I/TOT0001. http://innovation​.cms​.gov/Files/reports/MTM_Final_Report.pdf.

36.

McDonough RP, Doucette WR, Kumbera P, et al. An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosi. Value Health. 2005 Jan-Feb;8(1):24–31. [PubMed: 15841891]

37.

Moczygemba LR, Barner JC, Lawson KA, et al. Impact of telephone medication therapy management on medication and health-related problems, medication adherence, and Medicare Part D drug costs: a 6-month follow up. Am J Geriatr Pharmacother. 2011 Oct;9(5):328–38. [PubMed: 21865093]

38.

Moczygemba LR, Barner JC, Gabrillo ER, et al. Development and implementation of a telephone medication therapy management program for Medicare beneficiaries. Am J Health Syst Pharm. 2008 Sep 1;65(17):1655–60. [PubMed: 18714113]

39.

Moczygemba LR, Barner JC, Gabrillo ER. Outcomes of a Medicare Part D telephone medication therapy management program. 2012;52:E144. [PubMed: 23229976]

40.

Moore JM, Shartle D, Faudskar L, et al. Impact of a patient-centered pharmacy program and intervention in a high-risk group. J Manag Care Pharm. 2013 Apr;19(3):228–36. [PMC free article: PMC10438107] [PubMed: 23537457]

41.

Pai AB, Boyd A, Depczynski J, et al. Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study. Pharmacotherapy. 2009 Dec;29(12):1433–40. [PubMed: 19947803]

42.

Pai AB, Boyd A, Chavez A, et al. Health-related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: a 2-year randomized, controlled study. Hemodial Int. 2009 Jan;13(1):72–9. [PubMed: 19210281]

43.

Park JJ, Kelly P, Carter BL, et al. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc (Wash). 1996 Jul;NS36(7):443–51. [PubMed: 8840744]

44.

Pindolia VK, Stebelsky L, Romain TM, et al. Mitigation of medication mishaps via medication therapy management. Ann Pharmacother. 2009 Apr;43(4):611–20. [PubMed: 19336646]

45.

Planas LG, Crosby KM, Mitchell KD, et al. Evaluation of a hypertension medication therapy management program in patients with diabete. J Am Pharm Assoc (2003). 2009 Mar-Apr;49(2):164–70. [PubMed: 19289342]

46.

Roughead EE, Barratt JD, Ramsay E, et al. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail. 2009 Sep;2(5):424–8. [PubMed: 19808372]

47.

Sellors J, Kaczorowski J, Sellors C, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ. 2003 Jul 8;169(1):17–22. [PMC free article: PMC164937] [PubMed: 12847034]

48.

Shimp LA, Kucukarslan SN, Elder J, et al. Employer-based patient-centered medication therapy management program: Evidence and recommendations for future programs. :768. [PubMed: 23229963]

49.

Sidel VW, Beizer JL, Lisi-Fazio D, et al. Controlled study of the impact of educational home visits by pharmacists to high-risk older patients. J Community Health. 1990 Jun;15(3):163–74. [PubMed: 2195066]

50.

Staresinic AG. Early experience with medication management - Description and preliminary outcomes of a Medicare Part D medication therapy management program. J Pharm Soc Wis. 2007;(SEP-OCT):8–0.

51.

Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm. 2003 Jun 1;60(11):1123–9. [PubMed: 12816022]

52.

Touchette DR, Masica AL, Dolor RJ, et al. Safety-focused medication therapy management: a randomized controlled tria. J Am Pharm Assoc (2003). 2012 Sep-Oct;52(5):603–12. [PubMed: 23023840]

53.

Volume CI, Farris KB, Kassam R, et al. Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc (Wash). 2001 May-Jun;41(3):411–20. [PubMed: 11372906]

54.

Kassam R, Farris KB, Burback L, et al. Pharmaceutical care research and education project: pharmacists' interventions. J Am Pharm Assoc (Wash). 2001 May-Jun;41(3):401–10. [PubMed: 11372905]

55.

Welch EK, Delate T, Chester EA, et al. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries. Ann Pharmacother. 2009 Apr;43(4):603–10. [PubMed: 19318600]

56.

Williams ME, Pulliam CC, Hunter R, et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc. 2004 Jan;52(1):93–8. [PubMed: 14687321]

57.

Winston S, Lin YS. Impact on drug cost and use of Medicare part D of medication therapy management services delivered in 200. J Am Pharm Assoc (2003). 2009 Nov-Dec;49(6):813–20. [PubMed: 19858047]

58.

Witry MJ, Doucette WR, Gainer KL. Evaluation of the pharmaceutical case management program implemented in a private sector health plan. J Am Pharm Assoc (2003). 2011 Sep-Oct;51(5):631–5. [PubMed: 21896463]

59.

Wittayanukorn S, Westrick SC, Hansen RA, et al. Evaluation of medication therapy management services for patients with cardiovascular disease in a self-insured employer health plan. J Manag Care Pharm. 2013 Jun;19(5):385–95. [PMC free article: PMC10437721] [PubMed: 23697476]

60.

Yamada B. Comparison of Outcomes in the Medicare Medication Therapy Management Program within Kaiser Permanente California. 2012.